Humankind Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
2,489
+494
| +25% | +$220K | 0.27% | 49 |
|
|
2025
Q1 | $967K | Sell |
1,995
-72
| -3% | -$34.9K | 0.25% | 56 |
|
|
2024
Q4 | $832K | Buy |
2,067
+152
| +8% | +$61.2K | 0.21% | 61 |
|
|
2024
Q3 | $891K | Sell |
1,915
-24
| -1% | -$11.2K | 0.32% | 53 |
|
|
2024
Q2 | $909K | Sell |
1,939
-89
| -4% | -$41.7K | 0.24% | 57 |
|
|
2024
Q1 | $848K | Sell |
2,028
-236
| -10% | -$98.7K | 0.22% | 55 |
|
|
2023
Q4 | $921K | Sell |
2,264
-44
| -2% | -$17.9K | 0.27% | 52 |
|
|
2023
Q3 | $803K | Sell |
2,308
-39
| -2% | -$13.6K | 0.33% | 44 |
|
|
2023
Q2 | $826K | Buy |
2,347
+432
| +23% | +$152K | 0.32% | 44 |
|
|
2023
Q1 | $603K | Buy |
1,915
+123
| +7% | +$38.8K | 0.25% | 63 |
|
|
2022
Q4 | $517K | Sell |
1,792
-100
| -5% | -$28.9K | 0.22% | 66 |
|
|
2022
Q3 | $548K | Buy |
1,892
+56
| +3% | +$16.2K | 0.26% | 60 |
|
|
2022
Q2 | $517K | Buy |
1,836
+35
| +2% | +$9.86K | 0.25% | 61 |
|
|
2022
Q1 | $470K | Sell |
1,801
-379
| -17% | -$98.9K | 0.19% | 68 |
|
|
2021
Q4 | $479K | Buy |
2,180
+352
| +19% | +$77.3K | 0.6% | 55 |
|
|
2021
Q3 | $332K | Buy |
1,828
+663
| +57% | +$120K | 0.51% | 65 |
|
|
2021
Q2 | $235K | Buy |
+1,165
| New | +$235K | 0.42% | 73 |
|